BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17382325)

  • 1. Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha.
    Cho H; Ahn DR; Park H; Yang EG
    FEBS Lett; 2007 Apr; 581(8):1542-8. PubMed ID: 17382325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.
    Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ
    Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.
    Moin SM; Chandra V; Arya R; Jameel S
    Cell Microbiol; 2009 Sep; 11(9):1409-21. PubMed ID: 19489936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
    Na YR; Han KC; Park H; Yang EG
    Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.
    Ruas JL; Berchner-Pfannschmidt U; Malik S; Gradin K; Fandrey J; Roeder RG; Pereira T; Poellinger L
    J Biol Chem; 2010 Jan; 285(4):2601-9. PubMed ID: 19880525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1.
    Seo HW; Kim EJ; Na H; Lee MO
    FEBS Lett; 2009 Jan; 583(1):55-60. PubMed ID: 19071119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
    Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
    J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes.
    Choi JH; Cho HK; Choi YH; Cheong J
    Biochem J; 2009 Nov; 424(2):285-96. PubMed ID: 19712049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three conformational states of the p300 CH1 domain define its functional properties.
    Dial R; Sun ZY; Freedman SJ
    Biochemistry; 2003 Aug; 42(33):9937-45. PubMed ID: 12924942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803.
    McNeill LA; Hewitson KS; Claridge TD; Seibel JF; Horsfall LE; Schofield CJ
    Biochem J; 2002 Nov; 367(Pt 3):571-5. PubMed ID: 12215170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.
    Yang L; Jiang Y; Wu SF; Zhou MY; Wu YL; Chen GQ
    Carcinogenesis; 2008 Feb; 29(2):291-8. PubMed ID: 18024476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha.
    Peng ZG; Zhou MY; Huang Y; Qiu JH; Wang LS; Liao SH; Dong S; Chen GQ
    Oncogene; 2008 Jan; 27(6):839-47. PubMed ID: 17684492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha.
    Cascio S; Bartella V; Auriemma A; Johannes GJ; Russo A; Giordano A; Surmacz E
    Oncogene; 2008 Jan; 27(4):540-7. PubMed ID: 17653093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule.
    Kwon HS; Kim DR; Yang EG; Park YK; Ahn HC; Min SJ; Ahn DR
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5249-52. PubMed ID: 22789427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent.
    Kim HL; Yeo EJ; Chun YS; Park JW
    Int J Oncol; 2006 Jul; 29(1):255-60. PubMed ID: 16773207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53.
    Hansson LO; Friedler A; Freund S; Rudiger S; Fersht AR
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10305-9. PubMed ID: 12124396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300.
    Yu Z; Liu Y; Zhu J; Han J; Tian X; Han W; Zhao L
    J Biomol Struct Dyn; 2020 Jan; 38(1):1-12. PubMed ID: 30784357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications.
    Brahimi-Horn C; Mazure N; Pouysségur J
    Cell Signal; 2005 Jan; 17(1):1-9. PubMed ID: 15451019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
    Yoon H; Lim JH; Cho CH; Huang LE; Park JW
    Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1).
    Wilkins SE; Hyvärinen J; Chicher J; Gorman JJ; Peet DJ; Bilton RL; Koivunen P
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1563-71. PubMed ID: 19401150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.